Clinical Trial Update: To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole [Phase 4]

View source ↗

Summary

This Phase 4 trial assesses whether once-daily esomeprazole 40 mg improves heartburn in patients who continued to have heartburn after rabeprazole; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Heartburn

Drugs mentioned

• AcipHex (rabeprazole) (rabeprazole)
• Nexium (esomeprazole) (esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Heartburn | Phase 4 | Status: COMPLETED | Results posted: 2012-10-31